Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss

August 13, 2026 4:10 AM

Citizens analyst Jonathan Wolleben lowered the price target on Spruce Biosciences, Inc. (NASDAQ: SPRB) to $144.00 (from $150.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found